# Tobias Welte

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tobias-welte/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,756 |
| Field | Chronic Obstructive Pulmonary Disease (COPD) Research |
| h-index | 129 |
| i10-index | 793 |
| Last Known Institution | Medizinische Hochschule Hannover |
| OpenAlex ID | https://openalex.org/A5059857876 |
| ORCID iD | https://orcid.org/0000-0002-9947-7356 |
| Works | 1,955 |

## Researcher papers

Showing 12 of 13.

- [Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-3/)
- [Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis](https://scholariq.org/papers/intensive-insulin-therapy-and-pentastarch-resuscitation-in-severe-sepsis/)
- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-4/)
- [International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia](https://scholariq.org/papers/international-ers-esicm-escmid-alat-guidelines-for-the-management-of-hospital/)
- [European Respiratory Society guidelines for the management of adult bronchiectasis](https://scholariq.org/papers/european-respiratory-society-guidelines-for-the-management-of-adult/)
- [Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study](https://scholariq.org/papers/case-characteristics-resource-use-and-outcomes-of-10-021-patients-with-covid-19/)
- [Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections](https://scholariq.org/papers/procalcitonin-to-initiate-or-discontinue-antibiotics-in-acute-respiratory-tract/)
- [Epidemiology of sepsis in Germany: results from a national prospective multicenter study](https://scholariq.org/papers/epidemiology-of-sepsis-in-germany-results-from-a-national-prospective/)
- [Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial](https://scholariq.org/papers/pirfenidone-in-patients-with-progressive-fibrotic-interstitial-lung-diseases/)
- [Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021](https://scholariq.org/papers/executive-summary-surviving-sepsis-campaign-international-guidelines-for-the/)
- [The EMBARC European Bronchiectasis Registry: protocol for an international observational study](https://scholariq.org/papers/the-embarc-european-bronchiectasis-registry-protocol-for-an-international/)
- [Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method](https://scholariq.org/papers/expert-consensus-statements-for-the-management-of-covid-19-related-acute/)

## Researcher topics

- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes-2/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)

## Researcher university

- [Medizinische Hochschule Hannover](https://scholariq.org/institutions/medizinische-hochschule-hannover/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.